Purpose: To characterize preretinal neovascularizations (NV) and their corresponding branching routes in proliferative diabetic retinopathy (PDR) with optical coherence tomography angiography (OCTA) and compare the findings with fluorescein angiography (FA). Methods: In patients with PDR, angiograms were acquired with spectral-domain OCTA (CIRRUS 5000, OCTA AngioPlexTMCarl Zeiss Meditec, Inc.) and FA (Zeiss FF450PlusIR fundus camera or Spectralis HRA-OCT SLO, Heidelberg Engineering Inc.) and were consecutively evaluated. Neovascularization of the disc (NVD) and neovascularization elsewhere (NVE) were analyzed with 6 × 6 and 8 × 8 mm OCTA flow images and B-scans with flow registration. Segmentations of the vitreoretinal interface (VRI) and superficial retina were performed for analysis. Two independent investigators examined OCTA findings and compared them to corresponding FA. Results: Forty-two eyes of 30 patients with PDR were analyzed. A total of 76 NV with their corresponding proliferation routes were visualized and characterized, with 55 (72.4%) proliferating along the posterior hyaloid membrane (PHM), 14 (18.4%) along the epiretinal membrane, and 7 (9.2%) along the fibrovascular membrane. The posterior vitreous was partially detached in 37 of 42 eyes (88.1%), completely detached in 1 of 42 eyes (2.4%), and adherent in 1 of 42 eyes (2.4%). In 38 of 42 cases, OCTA was superior (n = 23) or equivalent (n = 15) to FA in detecting NV and provided a more detailed information of the neovascular vessels. In 4 of 42 study eyes, OCTA was inferior to FA. Conclusions: OCTA is a useful tool to detect NV in PDR. In comparison to FA, OCTA has the advantages that it is noninvasive and the image capture takes only seconds. We were able to identify all NV and characterize their corresponding proliferation routes in the VRI, the superficial retina slab, or the B-scan with flow registration. Through evading the masking effect of dye leakage in FA, OCTA is capable of better visualization of NV. FA, however, remains essential for the detection of all NV, since OCTA supplies a smaller detection field. Additionally, we identified the PHM as the main proliferating route of diabetic NV (72.4%), marking it as an important structure for sprouting vessels in neoangiogenesis in PDR.

1.
WHO Global report on Diabetes
[Available from: http://www.who.int/diabetes/global-report/en/
2.
Wong
TY
,
Cheung
N
,
Tay
WT
,
Wang
JJ
,
Aung
T
,
Saw
SM
, et al
Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study
.
Ophthalmology
.
2008
Nov
;
115
(
11
):
1869
75
.
[PubMed]
0161-6420
3.
Klein
R
,
Klein
BE
,
Moss
SE
,
Davis
MD
,
DeMets
DL
.
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years
.
Arch Ophthalmol
.
1984
Apr
;
102
(
4
):
527
32
.
[PubMed]
0003-9950
4.
Yu
Y
,
Zhang
J
,
Zhu
R
,
Zhao
R
,
Chen
J
,
Jin
J
, et al
The Profile of Angiogenic Factors in Vitreous Humor of the Patients with Proliferative Diabetic Retinopathy
.
Curr Mol Med
.
2017
Dec
;
17
(
4
):
280
6
.
[PubMed]
1566-5240
5.
Nawaz
IM
,
Rezzola
S
,
Cancarini
A
,
Russo
A
,
Costagliola
C
,
Semeraro
F
, et al
Human vitreous in proliferative diabetic retinopathy: characterization and translational implications
.
Prog Retin Eye Res
.
2019
Sep
;
72
:
100756
.
[PubMed]
1350-9462
6.
Ono
R
,
Kakehashi
A
,
Yamagami
H
,
Sugi
N
,
Kinoshita
N
,
Saito
T
, et al
Prospective assessment of proliferative diabetic retinopathy with observations of posterior vitreous detachment
.
Int Ophthalmol
.
2005
Feb-Apr
;
26
(
1-2
):
15
9
.
[PubMed]
0165-5701
7.
Akiba
J
,
Arzabe
CW
,
Trempe
CL
.
Posterior vitreous detachment and neovascularization in diabetic retinopathy
.
Ophthalmology
.
1990
Jul
;
97
(
7
):
889
91
.
[PubMed]
0161-6420
8.
Kishi
S
,
Shimizu
K
.
Clinical manifestations of posterior precortical vitreous pocket in proliferative diabetic retinopathy
.
Ophthalmology
.
1993
Feb
;
100
(
2
):
225
9
.
[PubMed]
0161-6420
9.
Vaz-Pereira
S
,
Morais-Sarmento
T
,
Esteves Marques
R
.
Optical coherence tomography features of neovascularization in proliferative diabetic retinopathy: a systematic review
.
Int J Retina Vitreous
.
2020
Jun
;
6
(
1
):
26
.
[PubMed]
2056-9920
10.
Anderson
W
,
Piggott
K
,
Bao
YK
,
Pham
H
,
Kavali
S
,
Rajagopal
R
.
Complete Posterior Vitreous Detachment Reduces the Need for Treatment of Diabetic Macular Edema
.
Ophthalmic Surg Lasers Imaging Retina
.
2019
Nov
;
50
(
11
):
e266
73
.
[PubMed]
2325-8160
11.
Kroll
P
,
Rodrigues
EB
,
Hoerle
S
.
Pathogenesis and classification of proliferative diabetic vitreoretinopathy
.
Ophthalmologica
.
2007
;
221
(
2
):
78
94
.
[PubMed]
0030-3755
12.
Fincham
GS
,
James
S
,
Spickett
C
,
Hollingshead
M
,
Thrasivoulou
C
,
Poulson
AV
, et al
Posterior Vitreous Detachment and the Posterior Hyaloid Membrane
.
Ophthalmology
.
2018
Feb
;
125
(
2
):
227
36
.
[PubMed]
0161-6420
13.
Gass
JD
,
Sever
RJ
,
Sparks
D
,
Goren
J
.
A combined technique of fluorescein funduscopy and angiography of the eye
.
Arch Ophthalmol
.
1967
Oct
;
78
(
4
):
455
61
.
[PubMed]
0003-9950
14.
Kwiterovich
KA
,
Maguire
MG
,
Murphy
RP
,
Schachat
AP
,
Bressler
NM
,
Bressler
SB
, et al
Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study
.
Ophthalmology
.
1991
Jul
;
98
(
7
):
1139
42
.
[PubMed]
0161-6420
15.
Lee
J
,
Rosen
R
.
Optical Coherence Tomography Angiography in Diabetes
.
Curr Diab Rep
.
2016
Dec
;
16
(
12
):
123
.
[PubMed]
1534-4827
16.
Huang
D
,
Jia
Y
,
Rispoli
M
,
Tan
O
,
Lumbroso
B
.
Optical Coherence Tomography Angiography of Time Course of Choroidal Neovascularization in Response to Anti-Angiogenic Treatment
.
Retina
.
2015
Nov
;
35
(
11
):
2260
4
.
[PubMed]
0275-004X
17.
Ishibazawa
A
,
Nagaoka
T
,
Yokota
H
,
Takahashi
A
,
Omae
T
,
Song
YS
, et al
Characteristics of Retinal Neovascularization in Proliferative Diabetic Retinopathy Imaged by Optical Coherence Tomography Angiography
.
Invest Ophthalmol Vis Sci
.
2016
Nov
;
57
(
14
):
6247
55
.
[PubMed]
0146-0404
18.
Savastano
MC
,
Federici
M
,
Falsini
B
,
Caporossi
A
,
Minnella
AM
.
Detecting papillary neovascularization in proliferative diabetic retinopathy using optical coherence tomography angiography
.
Acta Ophthalmol
.
2018
May
;
96
(
3
):
321
3
.
[PubMed]
1755-375X
19.
Rosenfeld
PJ
,
Durbin
MK
,
Roisman
L
,
Zheng
F
,
Miller
A
,
Robbins
G
, et al
ZEISS Angioplex™ Spectral Domain Optical Coherence Tomography Angiography: technical Aspects
.
Dev Ophthalmol
.
2016
;
56
:
18
29
.
[PubMed]
0250-3751
20.
Diaz
JD
,
Wang
JC
,
Oellers
P
,
Lains
I
,
Sobrin
L
,
Husain
D
, et al
Imaging the Deep Choroidal Vasculature Using Spectral Domain and Swept Source Optical Coherence Tomography Angiography
.
J Vitreoretin Dis
.
2018
May-Jun
;
2
(
3
):
146
54
.
[PubMed]
2474-1264
21.
Zhang
A
,
Zhang
Q
,
Chen
CL
,
Wang
RK
.
Methods and algorithms for optical coherence tomography-based angiography: a review and comparison
.
J Biomed Opt
.
2015
Oct
;
20
(
10
):
100901
.
[PubMed]
1083-3668
22.
Early Treatment Diabetic Retinopathy Study Research Group
.
Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs - An Extension of the Modified Airlie House Classification: ETDRS Report Number 10
.
Ophthalmology
.
2020
Apr
;
127
(
4
4S
):
S99
119
.
[PubMed]
0161-6420
23.
Lang
GE
,
Enders
C
,
Loidl
M
,
Lang
GK
,
Werner
JU
.
[Accurate OCT-angiography Interpretation - Detection and Exclusion of Artifacts]
.
Klin Monbl Augenheilkd
.
2017
Sep
;
234
(
9
):
1109
18
.
[PubMed]
1439-3999
24.
Hayashi
K
,
Sato
T
,
Manabe
SI
,
Hirata
A
,
Yoshimura
K
.
Posterior vitreous detachment in patients with diabetes mellitus
.
Jpn J Ophthalmol
.
2020
Mar
;
64
(
2
):
187
95
.
[PubMed]
0021-5155
25.
Bertelmann
T
,
Goos
C
,
Sekundo
W
,
Schulze
S
,
Mennel
S
.
Is Optical Coherence Tomography a Useful Tool to Objectively Detect Actual Posterior Vitreous Adhesion Status?
Case Rep Ophthalmol Med
.
2016
;
2016
:
3953147
.
[PubMed]
2090-6722
26.
Hwang
ES
,
Kraker
JA
,
Griffin
KJ
,
Sebag
J
,
Weinberg
DV
,
Kim
JE
.
Accuracy of Spectral-Domain OCT of the Macula for Detection of Complete Posterior Vitreous Detachment
.
Ophthalmol Retina
.
2020
Feb
;
4
(
2
):
148
53
.
[PubMed]
2468-7219
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.